| Jan 21 2021 |
China on the Move: Lesson from China’s National Negotiation of Drug Prices in 2020 |
Greenberg Traurig, LLP |
| Jan 20 2021 |
The Indefinite Peril Of Claim Drafting |
Foley & Lardner LLP |
| Jan 20 2021 |
USDA Publishes Final Rule for the Domestic Hemp Production Program |
Keller and Heckman LLP |
| Jan 19 2021 |
Employers Take a Shot at Managing the COVID-19 Vaccine |
Foley & Lardner LLP |
| Jan 19 2021 |
USDA Publishes Final Hemp Regulations |
Beveridge & Diamond PC |
| Jan 19 2021 |
Federal Court Enters Consent Decree Against Juice Processor for Distributing Adulterated Juice |
Keller and Heckman LLP |
| Jan 18 2021 |
Pennsylvania Medical Marijuana User May Proceed With Disability Discrimination And Retaliation Claims |
Jackson Lewis P.C. |
| Jan 18 2021 |
340B Administrative Dispute Resolution Goes Live Amid a Flurry of 340B Litigation |
Mintz |
| Jan 15 2021 |
EFSA Declares Mealworms Safe for Human Consumption |
Keller and Heckman LLP |
| Jan 15 2021 |
COVID-19 Weekly Newsletter: Biden Announces Ambitious Vaccination Plan |
Katten |
| Jan 15 2021 |
COVID-19: US State Policy Report – January 14, 2021 |
Squire Patton Boggs (US) LLP |
| Jan 14 2021 |
Privacy Tip #267 – Fertility Tracking App Settles with FTC |
Robinson & Cole LLP |
| Jan 13 2021 |
Food-Contact Chemicals Database Implications Questioned |
Keller and Heckman LLP |
| Jan 13 2021 |
Are Pre-Launch Statements Now Within the Range of the National Advertising Division? |
K&L Gates LLP |
| Jan 13 2021 |
Cannabis Legislation in Key States: Montana Voters Approve Legalizing Marijuana for Recreational Use |
ArentFox Schiff LLP |
| Jan 13 2021 |
Supreme Court Denies Certiorari in Challenge to Michigan’s Alcohol Delivery Law |
Squire Patton Boggs (US) LLP |
| Jan 13 2021 |
UK Announces Procedure for Authorization of New FCMs |
Keller and Heckman LLP |
| Jan 13 2021 |
FDA Clarifies Food Traceability List Descriptions and Publishes Related FAQ |
Keller and Heckman LLP |
| Jan 13 2021 |
USDA Announces Intent to Transfer Regulatory Authority Over Animal Biotechnology from FDA to USDA |
Beveridge & Diamond PC |
| Jan 12 2021 |
FDA’s Action Plan for Artificial Intelligence: Highlights and Insights for Developers |
Sheppard, Mullin, Richter & Hampton LLP |
| Jan 12 2021 |
Preemption Torpedoes State Law Claims against Generics Makers in Zantac MDL |
Faegre Drinker |
| Jan 12 2021 |
WARNING: California Prop 65 Enforcement of THC Listing from CBD Products Became Effective January 3, 2021 |
Squire Patton Boggs (US) LLP |
| Jan 12 2021 |
China Approves New Food-Contact Materials: January 12, 2021 |
Keller and Heckman LLP |
| Jan 12 2021 |
Regulatory Yearly Wrap 2020: Medical Device in India |
Nishith Desai Associates |
| Jan 12 2021 |
2020 Advertising Law Year in Review |
Proskauer Rose LLP |
| Jan 12 2021 |
FDA Regulation of CBD Requires Filling “Knowledge Gaps” |
Keller and Heckman LLP |
| Jan 12 2021 |
Oregon Issues New Guidance on Hard Seltzer Classification |
McDermott Will & Schulte LLP |
| Jan 11 2021 |
Medi-Cal Rx: California to Transition Medi-Cal Pharmacy Benefits to Fee-For-Service |
Sheppard, Mullin, Richter & Hampton LLP |
| Jan 11 2021 |
HHS Advisory Opinion Concludes Manufacturers Must Deliver 340 B Drugs to Contract Pharmacies |
McDermott Will & Schulte LLP |
| Jan 11 2021 |
American Axle Petitions for Cert. |
Schwegman, Lundberg & Woessner, P.A. |
| Jan 11 2021 |
Regulatory Yearly Wrap 2020: Pharmaceuticals In India |
Nishith Desai Associates |
| Jan 11 2021 |
EPA Releases Late-Term “Secret Science” Rule |
ArentFox Schiff LLP |
| Jan 11 2021 |
California Proposes Limits on the “Short-Form” Warning Option under Proposition 65 |
Keller and Heckman LLP |
| Jan 11 2021 |
Proposed Regulatory Changes to Safe Harbor Warning Provisions |
Polsinelli PC |
| Jan 9 2021 |
Looking Ahead: FDA in 2021 |
Mintz |
